Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-13 Sale |
2024-12-16 4:35 pm |
BIOCRYST PHARMACEUTICALS INC | BCRX | Hutson Nancy J Director |
7,000 | $7.54 | $52,780 | 86,638 (Direct) |
View |
| 2024-06-24 Sale |
2024-06-25 4:39 pm |
BIOCRYST PHARMACEUTICALS INC | BCRX | McKee Amy E Director |
8,600 | $6.32 | $54,352 | 27,831 (Direct) |
View |
| 2024-06-17 Sale |
2024-06-17 4:31 pm |
BIOCRYST PHARMACEUTICALS INC | BCRX | SANDERS MACHELLE Director |
4,689 | $6 | $28,134 | 27,742 (Direct) |
View |
| 2024-06-14 Sale |
2024-06-14 4:25 pm |
BIOCRYST PHARMACEUTICALS INC | BCRX | HEGGIE THERESA Director |
6,698 | $6.11 | $40,925 | 102,785 (Direct) |
View |
| 2024-05-30 Purchase |
2024-05-31 4:25 pm |
BIOCRYST PHARMACEUTICALS INC | BCRX | LEVIN ALAN G Director |
7,861 | $6.36 | $49,996 | 44,951 (Direct) |
View |
| 2024-05-24 Purchase |
2024-05-29 4:16 pm |
BIOCRYST PHARMACEUTICALS INC | BCRX | ASELAGE STEVE Director |
2,500 | $6.4 | $16,000 | 65,839 (Indirect Direct) |
View |
| 2024-05-20 Purchase |
2024-05-22 07:24 am |
BIOCRYST PHARMACEUTICALS INC | BCRX | Hutson Nancy J Director |
5,000 | $6.38 | $31,900 | 86,818 (Direct) |
View |
| 2024-05-20 Purchase |
2024-05-22 07:21 am |
BIOCRYST PHARMACEUTICALS INC | BCRX | MILANO VINCENT Director |
15,000 | $6.25 | $93,750 | 66,997 (Direct) |
View |
| 2024-05-14 Purchase |
2024-05-15 07:19 am |
BIOCRYST PHARMACEUTICALS INC | BCRX | Doyle Anthony Chief Financial Officer |
36,300 | $5.57 | $202,191 | 266,744 (Direct) |
View |
| 2024-05-14 Purchase |
2024-05-15 07:17 am |
BIOCRYST PHARMACEUTICALS INC | BCRX | Thackray Helen M. Chief R&D Officer |
30,000 | $5.86 | $175,800 | 272,139 (Direct) |
View |
| 2024-05-13 Purchase |
2024-05-15 07:14 am |
BIOCRYST PHARMACEUTICALS INC | BCRX | Galson Steven K Director |
21,940 | $5.49 | $120,451 | 51,551 (Direct) |
View |
| 2024-05-13 Purchase |
2024-05-15 07:11 am |
BIOCRYST PHARMACEUTICALS INC | BCRX | Barnes Alane P Chief Legal Officer |
5,000 | $5.53 | $27,650 | 300,762 (Direct) |
View |
| 2024-05-13 Purchase |
2024-05-15 07:08 am |
BIOCRYST PHARMACEUTICALS INC | BCRX | Stonehouse Jon P President & CEO |
30,000 | $5.55 | $166,500 | 1,167,770 (Indirect Direct) |
View |
| 2024-05-13 Purchase |
2024-05-15 07:04 am |
BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Chief Commercial Officer |
30,000 | $5.47 | $164,100 | 307,533 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-31 Tax Withholding |
2025-04-02 4:18 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Thackray Helen M. Chief R&D Officer |
7,525 | $7.5 | 377,318 (Direct) |
View |
| 2025-02-28 Option Award |
2025-03-04 4:18 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | MILANO VINCENT Director |
653 | $8.61 | 76,737 (Direct) |
View |
| 2024-12-19 Tax Withholding |
2024-12-23 4:19 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Chief Commercial Officer |
2,461 | $7.39 | 684,496 (Direct) |
View |
| 2024-12-19 Option Award |
2024-12-23 4:19 pm |
2025-12-19 2034-12-19 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Chief Commercial Officer |
386,900 | $0 | 684,496 (Direct) |
View |
| 2024-12-19 Tax Withholding |
2024-12-23 4:15 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Thackray Helen M. Chief R&D Officer |
6,096 | $7.39 | 645,793 (Direct) |
View |
| 2024-12-19 Option Award |
2024-12-23 4:15 pm |
2025-12-19 2034-12-19 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Thackray Helen M. Chief R&D Officer |
386,900 | $0 | 645,793 (Direct) |
View |
| 2024-12-19 Tax Withholding |
2024-12-23 4:11 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Doyle Anthony Chief Financial Officer |
2,461 | $7.39 | 627,967 (Direct) |
View |
| 2024-12-19 Option Award |
2024-12-23 4:11 pm |
2025-12-19 2034-12-19 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Doyle Anthony Chief Financial Officer |
370,800 | $0 | 627,967 (Direct) |
View |
| 2024-12-19 Tax Withholding |
2024-12-23 4:05 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Barnes Alane P Chief Legal Officer |
2,461 | $7.39 | 662,829 (Direct) |
View |
| 2024-12-19 Option Award |
2024-12-23 4:05 pm |
2025-12-19 2034-12-19 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Barnes Alane P Chief Legal Officer |
370,800 | $0 | 662,829 (Direct) |
View |
| 2024-12-19 Tax Withholding |
2024-12-23 4:01 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Stonehouse Jon P President & CEO |
14,010 | $7.39 | 2,209,359 (Direct) |
View |
| 2024-12-19 Option Award |
2024-12-23 4:01 pm |
2025-12-19 2034-12-19 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Stonehouse Jon P President & CEO |
1,112,350 | $0 | 2,209,359 (Direct) |
View |
| 2024-12-20 Gift |
2024-12-23 4:01 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Stonehouse Jon P President & CEO |
30,000 | $0 | 2,209,359 (Direct) |
View |
| 2024-12-14 Tax Withholding |
2024-12-17 4:22 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Chief Commercial Officer |
8,251 | $7.53 | 300,057 (Direct) |
View |
| 2024-12-14 Tax Withholding |
2024-12-17 4:16 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Stonehouse Jon P President & CEO |
27,525 | $7.53 | 1,141,019 (Direct) |
View |
| 2024-12-14 Tax Withholding |
2024-12-17 4:10 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Barnes Alane P Chief Legal Officer |
8,613 | $7.53 | 294,490 (Direct) |
View |
| 2024-12-14 Tax Withholding |
2024-12-17 4:06 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Doyle Anthony Chief Financial Officer |
7,890 | $7.53 | 259,628 (Direct) |
View |
| 2024-12-14 Tax Withholding |
2024-12-17 4:03 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Thackray Helen M. Chief R&D Officer |
7,150 | $7.53 | 264,989 (Direct) |
View |
| 2024-11-29 Option Award |
2024-12-02 4:06 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | MILANO VINCENT Director |
750 | $7.5 | 76,084 (Direct) |
View |
| 2024-08-30 Option Award |
2024-09-03 4:17 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | MILANO VINCENT Director |
647 | $8.69 | 75,334 (Direct) |
View |
| 2024-06-12 Option Award |
2024-06-14 4:33 pm |
2025-06-12 2034-06-12 |
BIOCRYST PHARMACEUTICALS INC | BCRX | SANDERS MACHELLE Director |
56,753 | $0 | 82,364 (Direct) |
View |
| 2024-06-12 Option Award |
2024-06-14 4:31 pm |
2025-06-12 2034-06-12 |
BIOCRYST PHARMACEUTICALS INC | BCRX | MILANO VINCENT Director |
56,753 | $0 | 124,620 (Direct) |
View |
| 2024-06-12 Option Award |
2024-06-14 4:30 pm |
2025-06-12 2034-06-12 |
BIOCRYST PHARMACEUTICALS INC | BCRX | McKee Amy E Director |
56,753 | $0 | 86,364 (Direct) |
View |
| 2024-06-12 Option Award |
2024-06-14 4:28 pm |
2025-06-12 2034-06-12 |
BIOCRYST PHARMACEUTICALS INC | BCRX | LEVIN ALAN G Director |
56,753 | $0 | 101,704 (Direct) |
View |
| 2024-06-12 Option Award |
2024-06-14 4:27 pm |
2025-06-12 2034-06-12 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Hutson Nancy J Director |
56,753 | $0 | 143,571 (Direct) |
View |
| 2024-06-12 Option Award |
2024-06-14 4:25 pm |
2025-06-12 2034-06-12 |
BIOCRYST PHARMACEUTICALS INC | BCRX | HEGGIE THERESA Director |
56,753 | $0 | 102,785 (Direct) |
View |
| 2024-06-12 Option Award |
2024-06-14 4:23 pm |
2025-06-12 2034-06-12 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Galson Steven K Director |
56,753 | $0 | 108,304 (Direct) |
View |
| 2024-06-12 Option Award |
2024-06-14 4:20 pm |
2025-06-12 2034-06-12 |
BIOCRYST PHARMACEUTICALS INC | BCRX | ASELAGE STEVE Director |
56,753 | $0 | 122,592 (Direct) |
View |
| 2024-06-12 Option Award |
2024-06-14 4:18 pm |
2025-06-12 2034-06-12 |
BIOCRYST PHARMACEUTICALS INC | BCRX | ABERCROMBIE GEORGE B Director |
56,753 | $0 | 86,364 (Direct) |
View |
| 2024-05-31 Option Award |
2024-06-03 4:33 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | HEGGIE THERESA Director |
870 | $6.46 | 52,730 (Direct) |
View |
| 2024-05-31 Option Award |
2024-06-03 4:29 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | MILANO VINCENT Director |
870 | $6.46 | 67,867 (Direct) |
View |
| 2024-03-31 Tax Withholding |
2024-04-02 4:21 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Thackray Helen M. Chief R&D Officer |
7,525 | $5.08 | 242,139 (Direct) |
View |
| 2024-02-29 Option Award |
2024-03-04 5:25 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | MILANO VINCENT Director |
999 | $5.63 | 51,997 (Direct) |
View |